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Adjunct treatment with levodopa in a patient
with dementia with Lewy bodies, delusions and
severe neuroleptic hypersensitivity syndrome:
some comments
Some patients with dementia with Lewy bodies
(DLB) exhibit persistent disturbing psychiatric
symptoms or challenging behavior despite treat-
ment with cholinesterase inhibitors. Such patients
pose one of the more difficult clinical management
problems faced in psychogeriatrics. Neuroleptics
are quite rightly avoided whenever possible and
the cautious “start low/go slow” maxim, which
most clinicians apply when neuroleptics have to
be used, often turns into a chronic “stay low/get
no (response)” situation. Memantine has recently
been reported to produce cognitive and global
benefits but without any significant improve-
ment in psychiatric symptoms (Aarsland et al.,
2009) and there are no other specific treatment
recommendations for this clinical scenario.
Dr. Majic and colleagues (2010, this issue)
describe the successful use of a high dose
of clozapine in conjuction with levodopa to
ameliorate motor side effects. Although heroic
pharmacotherapy is seldom to be advocated, and
particularly not in DLB patients who are especially
vulnerable to side effects, Dr. Majic’s case report
suggests that the effective management of psychosis
may sometimes be achieved by simultaneously
treating with clozapine and levodopa. Further
closely monitored case studies are needed to see
if this is indeed the case and readers of International
Psychogeriatrics might like to contact me directly
by email (i.g.mckeith@ncl.ac.uk) with reports –
positive or negative – of their experiences with this
combination, or indeed other treatments they have
used to manage “difficult” DLB psychosis.
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